Eli Lilly Wavered Over the Last Month: One of Wall Street's Biggest Banks Says 35% Gains Still to Come

Eli Lilly Wavered Over the Last Month: One of Wall Street's Biggest Banks Says 35% Gains Still to Come

Citigroup sees a path to 35% gains from here, but Eli Lilly's pricing headwinds, a slow oral GLP-1 launch, and a rival in freefall raise a real question about whether this pause signals opportunity or a longer stall ahead.

Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come

The post Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to Come appeared first on 24/7 Wall St.. Eli Lilly (NYSE:LLY) currently trades at $1,183.72, and the average analyst price target is $1,325.39. That puts the stock about 12% below where Wall…